Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3beta activity and associates with poor prognosis in human breast cancer.
暂无分享,去创建一个
Dung-Fang Lee | M. Hung | J. Hsu | W. Xia | Q. Ding | Dung-Fang Lee | Chun-Te Chen | Jer-Yen Yang | L. Li | Xiaoming Xie | Mien-Chie Hung | Qingqing Ding | Weiya Xia | Jung-Mao Hsu | Jaw-Ching Liu | Jer-Yen Yang | Chun-Te Chen | Xiaoming Xie | Long-Yuan Li | Xianghuo He | Xianghuo He | Jaw-Ching Liu
[1] D. Kimelman,et al. Role of Glycogen Synthase Kinase-3β in Neuronal Apoptosis Induced by Trophic Withdrawal , 2000, The Journal of Neuroscience.
[2] M. Hung,et al. Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition , 2004, Nature Cell Biology.
[3] M. Hung,et al. Degradation of Mcl-1 by β-TrCP Mediates Glycogen Synthase Kinase 3-Induced Tumor Suppression and Chemosensitization , 2006, Molecular and Cellular Biology.
[4] S. Korsmeyer,et al. BCL-2 family members and the mitochondria in apoptosis. , 1999, Genes & development.
[5] R. Craig,et al. The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2 , 1995, The Journal of cell biology.
[6] E. White,et al. DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells. , 2003, Genes & development.
[7] H. Pehamberger,et al. Mcl-1 Is a Novel Therapeutic Target for Human Sarcoma , 2004, Clinical Cancer Research.
[8] P. Krammer,et al. Tumor Immunology , 2018, Medical Immunology.
[9] M. Hung,et al. Systemic tumor suppression by the proapoptotic gene bik. , 2002, Cancer research.
[10] D. Hanahan,et al. The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors. , 1996, Genes & development.
[11] R. Gascoyne,et al. MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes. , 2001, Blood.
[12] C. Kurschner,et al. Modulation of Cell Death in Yeast by the Bcl-2 Family of Proteins* , 1997, The Journal of Biological Chemistry.
[13] J. Rohr,et al. Combinatorial biosynthesis of antitumor indolocarbazole compounds. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[14] S. Cory,et al. The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.
[15] Jun Qin,et al. Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. , 2005, Molecular cell.
[16] R. Craig. MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis , 2002, Leukemia.
[17] E. Henson,et al. Herceptin Sensitizes ErbB2–Overexpressing Cells to Apoptosis by Reducing Antiapoptotic Mcl-1 Expression , 2006, Clinical Cancer Research.
[18] Philip Cohen,et al. GSK3 takes centre stage more than 20 years after its discovery. , 2001 .
[19] D. Green,et al. Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. , 2006, Molecular cell.
[20] R. Jäger,et al. Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice , 1997, Oncogene.
[21] Jun Qin,et al. Erk Associates with and Primes GSK-3β for Its Inactivation Resulting in Upregulation of β-Catenin , 2005 .
[22] P. Cohen,et al. The renaissance of GSK3 , 2001, Nature Reviews Molecular Cell Biology.
[23] A. Reith,et al. Selective small‐molecule inhibitors of glycogen synthase kinase‐3 activity protect primary neurones from death , 2001, Journal of neurochemistry.
[24] T. McDonnell,et al. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18) , 1991, Nature.